I agree that obviously BP can sell a drug or diagnostic differently than Gerald can but just with the icon agreement alone if 1 million is what you sell to a 150 million dollar market than we are missing something and lympro is not what we have been led to believe I don't care if you push it from a hot dog stand if it's accurate convenient and saves BP as much as I understand it's a no brainer why in the world would it not grab a large market share quickly
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links